NCT00636545 2012-04-06
Genasense as a 2-hour Intravenous Infusion in Subjects With Solid Tumors
Genta Incorporated
Phase 1 Completed
Clinical Trials
5 trialsNCT00409383 2011-11-07
Abraxane and Temodar Plus Genasense in Advanced Melanoma
Genta Incorporated
Phase 1 Unknown
NCT00518895 2011-11-07
AGENDA
Genta Incorporated
Phase 3 Completed
NCT00517218 2008-02-11
This Study is Being Performed to Evaluate the Effect of Genasense on the Efficacy and the Safety of Rituximab/Fludarabine Combination Treatment in Previously Untreated Subjects With Chronic Lymphocyctic Leukemia(CLL)
Genta Incorporated
Phase 3 Withdrawn
NCT00543231 2007-10-12
A Phase I Study of G3139 Subcutaneous in Solid Tumors
Genta Incorporated
Phase 1 Completed